Terfenadine

特非那丁

Report date: 2023/02/16 20:00:58
NME

Base Information

Drug NameTerfenadine
Drug Alias Name特非那定
ClassificationSmall molecules
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsUrticariaRhinitis, Allergic, SeasonalRhinitis, Allergic
Global Approved IndicationsUrticariaRhinitis, Allergic
Approved Indications in ChinaUrticariaRhinitis, Allergic
Original Approved Country/TerritoryMainland China
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesHubei Huquan Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsUrticariaRhinitis, Allergic, SeasonalRhinitis, Allergic
Inactive IndicationsN/A

Other Information

ATC CodeR06AX12
Related LinksDrugBankKEGG